Background Cytomegalovirus (CMV) disease typically occurs during the first year after solid
organ transplantation, after cessation of antiviral prophylaxis. CMV occurring after the first …

The aim of our study was to assess the incidence course, influence on liver function,
diagnostic methods, prophylaxis of, and cost treatment effectiveness of CMV infection …

AIM: To study and compare the incidence and time of occurrence of cytomegalovirus (CMV)
infection in the posttransplant period in adult and pediatric liver transplant recipients …

Background. Cytomegalovirus (CMV) infection is an important cause of morbidity and
mortality following liver transplantation. Though oral ganciclovir may be used as a …

AA Boudreault, H. Xie, RM Rakita, JD Scott, CL Davis, M. Boeckh, AP Limaye. Risk factors
for late‐onset cytomegalovirus disease in donor seropositive/recipient seronegative kidney …

Background. Cytomegalovirus (CMV) disease after discontinuation of prophylaxis is a
significant problem for CMV-seronegative recipients of CMV-seropositive organs (donor …

INTRODUCTION: Despite recent advances in prevention and treatment, cytomegalovirus
(CMV) is still a major complication in transplant patients. This study sought to analyze the …

In utilizing a preemptive strategy to minimize the occurrence of symptomatic cytomegalovirus
(CMV) infection following liver transplant, only patients with proven CMV activity by direct …

Background: Cytomegalovirus (CMV) infection risk in the first month after transplantation is
felt to be minimal; however, the epidemiology has not been specifically investigated …

Cytomegalovirus (CMV) has been shown to be an important pathogen in liver transplant
recipients. The presence of primary infection and the use of OKT3 monoclonal antibodies …